395 related articles for article (PubMed ID: 35205407)
1. The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.
Hudler P; Urbancic M
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205407
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new
Lenglet M; Robriquet F; Schwarz K; Camps C; Couturier A; Hoogewijs D; Buffet A; Knight SJL; Gad S; Couvé S; Chesnel F; Pacault M; Lindenbaum P; Job S; Dumont S; Besnard T; Cornec M; Dreau H; Pentony M; Kvikstad E; Deveaux S; Burnichon N; Ferlicot S; Vilaine M; Mazzella JM; Airaud F; Garrec C; Heidet L; Irtan S; Mantadakis E; Bouchireb K; Debatin KM; Redon R; Bezieau S; Bressac-de Paillerets B; Teh BT; Girodon F; Randi ML; Putti MC; Bours V; Van Wijk R; Göthert JR; Kattamis A; Janin N; Bento C; Taylor JC; Arlot-Bonnemains Y; Richard S; Gimenez-Roqueplo AP; Cario H; Gardie B
Blood; 2018 Aug; 132(5):469-483. PubMed ID: 29891534
[TBL] [Abstract][Full Text] [Related]
3. Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.
Bartels M; van der Zalm MM; van Oirschot BA; Lee FS; Giles RH; Kruip MJ; Gitz-Francois JJ; Van Solinge WW; Bierings M; van Wijk R
Hum Mutat; 2015 Nov; 36(11):1039-42. PubMed ID: 26224408
[TBL] [Abstract][Full Text] [Related]
4. rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics.
Remenyi G; Bereczky Z; Gindele R; Ujfalusi A; Illes A; Udvardy M
Pathol Oncol Res; 2021; 27():1609987. PubMed ID: 34899081
[TBL] [Abstract][Full Text] [Related]
5. Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient.
Núñez-Martínez PM; Taja-Chayeb L; Ramírez-Otero MA; Fragoso-Ontiveros V; Wegman-Ostrosky T; Cruz-Robles D; Vidal Millán S
Bol Med Hosp Infant Mex; 2021 May; 78(4):341-345. PubMed ID: 33938902
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
7. Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis.
Negro A; Graiani G; Nicoli D; Farnetti E; Casali B; Verzicco I; Tedeschi S; Ghirarduzzi A; Cannone V; Marco LDE; Filice A; Gemelli G; Giunta A; Cabassi A
J Hypertens; 2020 Feb; 38(2):340-346. PubMed ID: 31568062
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
[TBL] [Abstract][Full Text] [Related]
9. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT
Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285
[TBL] [Abstract][Full Text] [Related]
10. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
11. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
12. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
13. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
[TBL] [Abstract][Full Text] [Related]
14. Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein.
Liu SJ; Wang JY; Peng SH; Li T; Ning XH; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
Genet Med; 2018 Oct; 20(10):1266-1273. PubMed ID: 29595810
[TBL] [Abstract][Full Text] [Related]
15. [Von Hippel-Lindau syndrome - a case report].
Figlus M; Kaczorowska B; Jaskólski DJ; Kępczyński Ł
Pol Merkur Lekarski; 2018 May; 44(263):248-252. PubMed ID: 29813043
[TBL] [Abstract][Full Text] [Related]
16. Von Hippel-Lindau disease and endocrine tumour susceptibility.
Woodward ER; Maher ER
Endocr Relat Cancer; 2006 Jun; 13(2):415-25. PubMed ID: 16728571
[TBL] [Abstract][Full Text] [Related]
17. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
18. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
19. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
20. Systemic VHL gene functions and the VHL disease.
Bader HL; Hsu T
FEBS Lett; 2012 Jun; 586(11):1562-9. PubMed ID: 22673568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
